Cargando…
Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts
Renal fibrosis is the final common pathway of chronic kidney disease (CKD), and no effective medication is available clinically for managing its progression. Metformin was initially developed as an anti-diabetic drug and recently gained attention for its potential in the treatment of other diseases....
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783880/ https://www.ncbi.nlm.nih.gov/pubmed/26805826 http://dx.doi.org/10.3390/ijms17020146 |
_version_ | 1782420169097740288 |
---|---|
author | Shen, Yang Miao, Naijun Xu, Jinlan Gan, Xinxin Xu, Dan Zhou, Li Xue, Hong Zhang, Wei Lu, Limin |
author_facet | Shen, Yang Miao, Naijun Xu, Jinlan Gan, Xinxin Xu, Dan Zhou, Li Xue, Hong Zhang, Wei Lu, Limin |
author_sort | Shen, Yang |
collection | PubMed |
description | Renal fibrosis is the final common pathway of chronic kidney disease (CKD), and no effective medication is available clinically for managing its progression. Metformin was initially developed as an anti-diabetic drug and recently gained attention for its potential in the treatment of other diseases. In this study, we investigated its effects on renal fibrosis in a mouse model of unilateral ureteral obstruction (UUO) in vivo and in angiotensin II (Ang II)–treated renal fibroblast NRK-49F cells in vitro. Our data showed that UUO induced renal fibrosis and combined with the activation of ERK signaling, the upregulation of fibronectin, collagen I, and transforming growth factor-β (TGF-β). The administration of metformin inhibited the activation of ERK signaling and attenuated the production of extracellular matrix (ECM) proteins and collagen deposition in the obstructed kidneys. In cultured renal fibroblasts, Ang II increased the expression of fibronectin and collagen I and also activated ERK signaling and TGF-β in a time-dependent manner. Pretreatment of the cells with metformin blocked Ang II–induced ERK signaling activation and ECM overproduction. Our results show that metformin prevents renal fibrosis, possibly through the inhibition of ERK signaling, and may be a novel strategy for the treatment of renal fibrosis. |
format | Online Article Text |
id | pubmed-4783880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-47838802016-03-14 Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts Shen, Yang Miao, Naijun Xu, Jinlan Gan, Xinxin Xu, Dan Zhou, Li Xue, Hong Zhang, Wei Lu, Limin Int J Mol Sci Article Renal fibrosis is the final common pathway of chronic kidney disease (CKD), and no effective medication is available clinically for managing its progression. Metformin was initially developed as an anti-diabetic drug and recently gained attention for its potential in the treatment of other diseases. In this study, we investigated its effects on renal fibrosis in a mouse model of unilateral ureteral obstruction (UUO) in vivo and in angiotensin II (Ang II)–treated renal fibroblast NRK-49F cells in vitro. Our data showed that UUO induced renal fibrosis and combined with the activation of ERK signaling, the upregulation of fibronectin, collagen I, and transforming growth factor-β (TGF-β). The administration of metformin inhibited the activation of ERK signaling and attenuated the production of extracellular matrix (ECM) proteins and collagen deposition in the obstructed kidneys. In cultured renal fibroblasts, Ang II increased the expression of fibronectin and collagen I and also activated ERK signaling and TGF-β in a time-dependent manner. Pretreatment of the cells with metformin blocked Ang II–induced ERK signaling activation and ECM overproduction. Our results show that metformin prevents renal fibrosis, possibly through the inhibition of ERK signaling, and may be a novel strategy for the treatment of renal fibrosis. MDPI 2016-01-22 /pmc/articles/PMC4783880/ /pubmed/26805826 http://dx.doi.org/10.3390/ijms17020146 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shen, Yang Miao, Naijun Xu, Jinlan Gan, Xinxin Xu, Dan Zhou, Li Xue, Hong Zhang, Wei Lu, Limin Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts |
title | Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts |
title_full | Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts |
title_fullStr | Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts |
title_full_unstemmed | Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts |
title_short | Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts |
title_sort | metformin prevents renal fibrosis in mice with unilateral ureteral obstruction and inhibits ang ii-induced ecm production in renal fibroblasts |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783880/ https://www.ncbi.nlm.nih.gov/pubmed/26805826 http://dx.doi.org/10.3390/ijms17020146 |
work_keys_str_mv | AT shenyang metforminpreventsrenalfibrosisinmicewithunilateralureteralobstructionandinhibitsangiiinducedecmproductioninrenalfibroblasts AT miaonaijun metforminpreventsrenalfibrosisinmicewithunilateralureteralobstructionandinhibitsangiiinducedecmproductioninrenalfibroblasts AT xujinlan metforminpreventsrenalfibrosisinmicewithunilateralureteralobstructionandinhibitsangiiinducedecmproductioninrenalfibroblasts AT ganxinxin metforminpreventsrenalfibrosisinmicewithunilateralureteralobstructionandinhibitsangiiinducedecmproductioninrenalfibroblasts AT xudan metforminpreventsrenalfibrosisinmicewithunilateralureteralobstructionandinhibitsangiiinducedecmproductioninrenalfibroblasts AT zhouli metforminpreventsrenalfibrosisinmicewithunilateralureteralobstructionandinhibitsangiiinducedecmproductioninrenalfibroblasts AT xuehong metforminpreventsrenalfibrosisinmicewithunilateralureteralobstructionandinhibitsangiiinducedecmproductioninrenalfibroblasts AT zhangwei metforminpreventsrenalfibrosisinmicewithunilateralureteralobstructionandinhibitsangiiinducedecmproductioninrenalfibroblasts AT lulimin metforminpreventsrenalfibrosisinmicewithunilateralureteralobstructionandinhibitsangiiinducedecmproductioninrenalfibroblasts |